Pioneering A Big Idea with An Unborrowed Vision

June 28, 2017

Noubar Afeyan, Ph.D.
Co-founder and Chairman, Moderna Therapeutics
CEO, Flagship Pioneering

In April 2015, Luke Timmerman wrote an article that appeared in Forbes titled, ‘The Oprahs of Biotech: People Who Can Go by First Name Only.’

‘Stéphane’ was among the names in Luke’s article.

Read more

 

 

Building The Digital Biotech Company

June 22, 2017

Stéphane Bancel, Chief Executive Officer, Moderna

My first leadership roles in the biopharma industry were within a large pharma company. This was a phenomenal experience. I gained a strong understanding of how organizational infrastructures support established, global R&D, manufacturing and commercial enterprises to advance medicines to help patients. But I also saw how silos of information,  a blend of analog processes and digital ones, and a lack of integration among heterogeneous systems and geographic locations led to many lost opportunities.

Read more

 

 

Advancing Disruptive mRNA Vaccines:  Opportunity and Obligation

May 4, 2017

Michael Watson, MB ChB, MRCP, AFPM
President, Valera, Moderna’s infectious disease-focused venture

Evan Rachlin, MD
Senior Director of Strategic Planning, Moderna

As physicians by training, we’re often asked by friends and family why we made the decision to jump from clinical care to the biopharmaceutical space. The potential to bring new medicines to patients – medicines that can impact and improve many, many lives – is tantalizing.

What attracted both of us to Moderna specifically was its potential to bring not just one or two new medicines to market – but to possibly launch an entire new class of medicines that could help people impacted by many types of diseases. Go big or go home.

Read more

 

 
 

A Milestone Week at Moderna

April 28, 2017

Stéphane Bancel
Chief Executive Officer, Moderna

Dear All,

Welcome to the Moderna Blog.

We’ve considered launching this blog for a while – and this week seemed like the perfect time.

Why launch a blog?  We wanted to have a channel to communicate directly and more personally to all those interested in Moderna.

We plan to share insights and our viewpoint on important topics related to our company, our science and pipeline, and our industry as a whole. The blog also will give various team members a platform to talk about what motivates, inspires and drives them in their work here.

Read more